Show simple item record

dc.contributor.authorHabil, N
dc.contributor.authorBeal, J
dc.contributor.authorFoey, Andrew

Probiotics confer health benefits through many mechanisms including modulation of the gut immune system, dut macrophages regulate immune homeostasis, mounting tolerogenic responses to food and commensal bacteria or immune inflammatory responses to pathogens. Local environment and macrophage subset determine immune response and tolerance, associated with an M2-like phenotype and inflammatory activation with an Ml-like phenotype. Subset predominance will determine immunomodulatory effects of probiotic species such as Lactobacillus casei strain Shirota (LcS). The aim of this study was to investigate differential regulatory effects of LcS on Ml and M2 macrophage subsets. PMA or vitamin D3 differentiated THP-1 human monocytic cells were used to investigate heat-killed LcS and secreted protein tmmunoregulation of Ml and M2 cytokine production, respectively. Additionally, regulation of CD 14lo M2 and CD 14hiMl function was investigated Cytokine expression was measured by ELISA and NFkB activity by reporter assay. Both HK-LcS and SP-LcSaugmented IL-lβ, suppressed IL-6 and differentially regulated TNFα and IL-8, dependent on macrophage subset. HK-LcS and LcS-SP augmented CD14hi Ml TNFa whereas suppressed CD14lo M2 IL-6 and CD14hi Ml NFkB. In conclusion, LcS differentially regulates macrophage cytokines and NFkB activation, is subset-dependent and suggests a cautionary approach to probiotic treatment of mucosal inflammation. Copyright © 2012 by New Century Health Publishers, LLC.

dc.titleLactobacillus casei strain Shirota selectively modulates macrophage subset cytokine production
dc.typeJournal Article
plymouth.journalInternational Journal of Probiotics and Prebiotics
plymouth.organisational-group/Plymouth/Faculty of Health
plymouth.organisational-group/Plymouth/Faculty of Science and Engineering
plymouth.organisational-group/Plymouth/Faculty of Science and Engineering/School of Biological and Marine Sciences
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA/UoA01 Clinical Medicine
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA/UoA01 Clinical Medicine/UoA01 Clinical Medicine
plymouth.organisational-group/Plymouth/Research Groups
plymouth.organisational-group/Plymouth/Research Groups/Institute of Translational and Stratified Medicine (ITSMED)
plymouth.organisational-group/Plymouth/Research Groups/Institute of Translational and Stratified Medicine (ITSMED)/CBR
plymouth.organisational-group/Plymouth/Users by role
plymouth.organisational-group/Plymouth/Users by role/Academics
dc.rights.embargoperiodNot known
rioxxterms.typeJournal Article/Review

Files in this item


This item appears in the following Collection(s)

Show simple item record

All items in PEARL are protected by copyright law.
Author manuscripts deposited to comply with open access mandates are made available in accordance with publisher policies. Please cite only the published version using the details provided on the item record or document. In the absence of an open licence (e.g. Creative Commons), permissions for further reuse of content should be sought from the publisher or author.
Theme by 
Atmire NV